Piramal Pharma Limited (BOM:543635)
India
· Delayed Price · Currency is INR 208.60
-9.45 (-4.33%)
At close: Feb 21, 2025
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 277.15 billion as of February 21, 2025. Its market cap has increased by 50.34% in one year.
Market Cap
277.15B
Enterprise Value
320.93B
Revenue
89.49B
Ranking
n/a
PE Ratio
712.46
Stock Price
208.60
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 277.15B, an increase of 22.24%. That is a compound annual growth rate of 8.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 277.15B | -21.48% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 15.61T |
| Tata Consultancy Services | 13.70T |
| HDFC Bank | 12.95T |
| Bharti Airtel | 9,798.65B |
| ICICI Bank | 8,708.47B |
| Infosys | 7,518.72B |
| State Bank of India | 6,443.58B |
| Hindustan Unilever | 5,266.96B |